Cannabinoid hyperemesis syndrome: A case report and review of pathophysiology

Clinical Medicine and Research

Volumn 12, Issue 1-2, 2014, Pages 65-67

  Iacopetti, Corina L ^a   Packer, Clifford D ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

Cannabis; Cyclic vomiting; Hyperemesis; Marijuana

Indexed keywords

CANNABIS; CITALOPRAM; OMEPRAZOLE; ONDANSETRON; CANNABINOID;

ABDOMINAL PAIN; ADULT; ARTICLE; CANNABINOID HYPEREMESIS SYNDROME; CANNABIS SMOKING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYCLIC VOMITING SYNDROME; CYSTOGRAPHY; DEHYDRATION; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM FUNCTION DISORDER; DIZZINESS; ECHOGRAPHY; ELECTROLYTE DISTURBANCE; ESOPHAGOGASTRODUODENOSCOPY; HUMAN; HYPOCHLOREMIA; HYPOKALEMIA; HYPONATREMIA; LABORATORY TEST; LEUKOCYTOSIS; MALE; NAUSEA AND VOMITING; PATHOPHYSIOLOGY; STOMACH EMPTYING; STOMACH FUNCTION DISORDER; TOBACCO USE; CANNABIS ADDICTION; CHEMICALLY INDUCED; NAUSEA; SYNDROME; VOMITING;

ADULT; CANNABINOIDS; CANNABIS; HUMANS; MALE; MARIJUANA ABUSE; NAUSEA; SYNDROME; VOMITING;

EID: 84908614169     PISSN: 15394182     EISSN: 15546179     Source Type: Journal    
DOI: 10.3121/cmr.2013.1179     Document Type: Article

References (12)

1. Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, Bruffaerts R, de Girolamo G, Gureje O, Huang Y, Karam A, Kostyuchenko S, Lepine JP, Mora ME, Neumark Y, Ormel JH, Pinto-Meza A, Posada-Villa J, Stein DJ, Takeshima T, Wells JE. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med 2008;5:e141.
2. Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 2004;53:1566–1570.
3. Simonetto DA, Oxentenko AS, Herman ML, Szostek JH. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc 2012;87:114–119.
4. Wallace EA, Andrews SE, Garmany CL, Jelley MJ. Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm. South Med J. 2011;104:659–664.
5. Galli, JA, Sawaya RA, Friedenberg FK. Cannabinoid hyperemesis syndrome. Curr Drug Abuse Rev 2011;4: 241–249.
6. Toennes SW, Ramaekers JG, Theunissen EL, Moeller MR, Kauert GF. Comparison of cannabinoid pharmacokinetic properties in occasional and heavy user smoking a marijuana or placebo joint. J Anal Toxicol 2008;32:470–477.
7. Parker LA, Rock EM, Limebeer CL. Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol 2011;163: 1411–1422.
8. Kwiatkowska M, Parker LA, Burton P, Mechoulam R. A comparative analysis of the potential of cannabinoids to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew). Psychopharmacology (Berl) 2004;174:254–259.
9. Parker LA, Kwiatkowska M, Burton P, Mechoulam R. Effect of cannabinoids on lithium-induced vomiting in the Sincus murinus (house musk shrew). Psychopharmacol (Berl) 2004;171:156–161.
10. Varvel SA, Bridgen DT, Tao Q, Thomas BF, Martin BR, Lichtman AH. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. J Pharmacol Exp Ther 2005;314:329–337.
11. Smirnov MS, Kiyatkin EA. Behavioral and temperature effects of delta 9-tetrahydrocannabinol in human-relevant doses in rats. Brain Res 2008;1228:145–160.
12. Malone DT, Taylor DA. Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat. Br J Pharmacol 1998;124:1419–1424.